Keywords: immtech, pafuramidine, enters, ph, iib, trial, usa

Immtech's pafuramidine enters Ph IIb trial

Article | 16 April 2007

Print This

The USA's Immtech Pharmaceuticals has initiated a Phase IIb clinical trial of its oral drug candidate pafuramidine maleate in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in